Waratah NSW

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Chronic lymphocytic leukaemia2 trials
• Lung cancer1 trial

Phase

• Phase 33 trials

Status

• Active, not recruiting3 trials

Lead sponsor

• Acerta Pharma BV2 trials
• AstraZeneca1 trial

Running trials

• Active, not recruiting

  Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment

  NCT05261399· Phase 3· AstraZeneca· Source

• Active, not recruiting

  Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Participants With High Risk Chronic Lymphocytic Leukemia (CLL)

  NCT02477696· Phase 3· Acerta Pharma BV· Source

• Active, not recruiting

  Acalabrutinib, Obinutuzumab and Chlorambucil in Treatment naïve CLL

  NCT02475681· Phase 3· Acerta Pharma BV· Source